Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample
Blog
Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup
The RuleOut team has created a novel approach that can exponentially increase COVID-19 testing capacity.
Murrieta Genomics and SimplSeq to Participate in Life Science Nation's Digital RESI Partnering Event
Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services
Press Releases
Goal is to provide a greater amount of personalized patient data to assist with pharmacogenomic and personalized medicine research
The Board will bring industry specific and broader business experience to bear as genomic sequencing startups build their business models.
“UC Riverside is a virtual gold mine of intellectual property in the genomic area”
"We are excited to team with SeqOnce to develop, showcase and demonstrate their libraries to our growing base of customers